Literature DB >> 6269480

In vitro antimicrobial activity of ceftizoxime against glucose-nonfermentative gram-negative rods.

E Yabuuchi, T Ito, E Tanimura, N Yamamoto, A Ohyama.   

Abstract

Ceftizoxime, a new cephalosporin, was active against Pseudomonas cepacia, Flavobacterium meningosepticum, Alcaligenes faecalis, and Acinetobacter calcoaceticus and was more potent against Pseudomonas aeruginosa and Pseudomonas putida than was carbenicillin.

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6269480      PMCID： PMC181645          DOI： 10.1128/AAC.20.1.136

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  4 in total

1.  Nonfermentative bacilli associated with man. 3. Pathogenicity and antibiotic susceptibility.

Authors:  M M Pedersen; E Marso; M J Pickett
Journal:  Am J Clin Pathol       Date:  1970-08       Impact factor: 2.493

2.  Pseudomonas cepacia from blood of a burn patient.

Authors:  E Yabuuchi; N Miyajima; H Hotta; A Oyama; N Tanaka
Journal:  Med J Osaka Univ       Date:  1970-12

3.  Antibacterial activity of ceftizoxime, a beta-lactamase-stable cephalosporin.

Authors:  K P Fu; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1980-04       Impact factor: 5.191

4.  Ceftizoxime (FK 749), a new parenteral cephalosporin: in vitro and in vivo antibacterial activities.

Authors:  T Kamimura; Y Matsumoto; N Okada; Y Mine; M Nishida; S Goto; S Kuwahara
Journal:  Antimicrob Agents Chemother       Date:  1979-11       Impact factor: 5.191
  4 in total
  8 in total

1.  In vitro activities of quinolones, beta-lactams, tobramycin, and trimethoprim-sulfamethoxazole against nonfermentative gram-negative bacilli.

Authors:  R J Fass; J Barnishan; M C Solomon; L W Ayers
Journal:  Antimicrob Agents Chemother       Date:  1996-06       Impact factor: 5.191

2.  Antimicrobial susceptibility of flavobacteria as determined by agar dilution and disk diffusion methods.

Authors:  J C Chang; P R Hsueh; J J Wu; S W Ho; W C Hsieh; K T Luh
Journal:  Antimicrob Agents Chemother       Date:  1997-06       Impact factor: 5.191

Review 3.  The third generation cephalosporins.

Authors:  B Farber; R C Moellering
Journal:  Bull N Y Acad Med       Date:  1982-11

4.  Effect of temperature on antimicrobial susceptibilities of Pseudomonas maltophilia.

Authors:  P F Wheat; T G Winstanley; R C Spencer
Journal:  J Clin Pathol       Date:  1985-09       Impact factor: 3.411

5.  Reappraisal of the antimicrobial susceptibilities of Chryseobacterium and Flavobacterium species and methods for reliable susceptibility testing.

Authors:  S L Fraser; J H Jorgensen
Journal:  Antimicrob Agents Chemother       Date:  1997-12       Impact factor: 5.191

Review 6.  A retrospective analysis of pharmacokinetic-pharmacodynamic parameters as indicators of the clinical efficacy of ceftizoxime.

Authors:  A Sánchez-Navarro; C I Colino; M M Sánchez Recio
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

7.  Treatment of bacterial meningitis with ceftizoxime.

Authors:  G D Overturf; D C Cable; D N Forthal; C Shikuma
Journal:  Antimicrob Agents Chemother       Date:  1984-02       Impact factor: 5.191

8.  Pharmacokinetics of multiple doses of ceftizoxime and their influence on fecal flora.

Authors:  H Lode; H Warns; B Kemmerich; H Knothe; P Koeppe
Journal:  Eur J Clin Microbiol       Date:  1983-04       Impact factor: 3.267
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.